The company announced it has successfully started imaging patients with its first prototype of its device using both ...

The device offers a shortened procedure time and efficient, effective SMILE for patients with myopia, with or without ...

Perceive Pharma raised $15M in Series A funding to develop neuroprotective therapeutics for glaucoma and other conditions.

Bonnie Henderson, MD, founder and program director of the EnVision Summit, talked with Ophthalmology Times about the ...

Patient discussions are crucial for tailoring IOL choices, ensuring alignment with lifestyle, needs, and surgical outcome ...

The ASO has appointed three new board members to enhance advocacy and efficiency within the organization. Rahul Chakrabarti ...

FYB203, a biosimilar to aflibercept, received UK MHRA approval for multiple retinal conditions and will be marketed as ...

Alcon announced the US launch of SYSTANE PRO Preservative-Free (PF) as part of the company’s dry eye products. The ...

The state-of-the-art facility more than doubles the institute’s footprint, enhancing patient care, research, and education.

Combining eyelid pressure patching with AMT effectively heals persistent corneal epithelial defects, offering rapid ...

Luxa Biotechnology LLC announced that the US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced ...

At the Envision Summit 2025 in San Juan, Puerto Rico, retina program chairs Geeta Lalwani, MD, and Majda Hadziahmetovic, MD, ...